Immatics N.V. (IMTX) valuation against sector peers: P/B 1.8, free-cash-flow yield −20.7%.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Metric	IMTX	Sector median	vs median
P/E	—	22.4 · n=28	—
P/B	1.8	3.6 · n=45	49% below
P/S	—	4.5 · n=40	—
EV/EBIT	—	20.8 · n=28	—
Free-cash-flow yield	−20.7%	3.5% · n=41	699% below
Dividend yield	0.00%	0.12% · n=100	100% below
Return on equity	−37.1%	6.8% · n=56	649% below
Return on invested capital	—	7.0% · n=47	—
Gross margin	—	70.2% · n=39	—
Net debt / EBITDA	—	1.39 · n=26	—

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
NVSNovartis AG	21.3	6.5	17.9	5.9%	2.5%	9/10
NO NOVNNovartis AG	21.2	6.4	17.8	5.9%	2.9%	10/10
AZ AZNAstraZeneca plc	25.7	5.4	20.9	4.5%	1.9%	6/10
AZ AZNAstraZeneca PLC	25.7	5.4	20.9	4.5%	1.3%	6/10
NV NVONovo Nordisk A/S	11.2	5.9	9.8	5.2%	4.8%	7/10
GS GSKGSK plc	13.8	4.8	11.3	8.1%	3.7%	10/10
SNYSanofi	11.8	1.3	16.3	7.8%	5.0%	7/10
SA SANSanofi SA	11.8	1.3	16.2	7.8%	5.5%	8/10
TE TEVATeva Pharmaceutical Industries Limited	66.0	6.0	37.2	2.9%	0.0%	6/10
ALCAlcon	34.7	1.5	27.3	5.1%	0.4%	4/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 05 Mar 2026

Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.

Cookie settings